AKAN compared with DFTX: revenue, margins and what each company keeps, and the suppliers and customers both name

AKANAkanda Corp.

Mkt capRevenueRevenue

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AKANAkanda Corp.

DFTXDefinium Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

AKAN: latest quarter not drawable. DFTX: latest quarter not drawable.Method ›

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: AKAN, DFTX.

Role chip = supplier or customerSource: SEC EDGAR

rebased to 0%

AKAN, solidDFTX, dashed

AKANAkanda Corp.

1.06▲+1.92%

Mkt cap$2.1M

DFTXDefinium Therapeutics, Inc.

33.41▼−0.01%

Regular sessionNov 4 '26

Mkt cap$4.4B

Compare

Regular sessionNov 4 '26

AKANAkanda Corp.

DFTXDefinium Therapeutics, Inc.

1.06▲+1.92%

Price

33.41▼−0.01%

$2.1M

Mkt cap

$4.4B

AKAN1.06▲+1.92%vsDFTX33.41▼−0.01%Regular sessionNov 4 '26